Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Pharm Educ ; 84(8): ajpe7892, 2020 08.
Article in English | MEDLINE | ID: mdl-32934387

ABSTRACT

Providing health care for children is a unique specialty, and pediatric patients represent approximately 25% of the population. Education of pharmacy students on patients across the lifespan is required by current Accreditation Council for Pharmacy Education standards and outcomes; thus, it is essential that pharmacy students gain a proficiency in caring for children. A collaborative panel of pediatric faculty members from schools and colleges of pharmacy was established to review the current literature regarding pediatric education in Doctor of Pharmacy curricula and establish updated recommendations for the provision of pediatric pharmacy education. This statement outlines five recommendations supporting inclusion of pediatric content and skills in Doctor of Pharmacy curricula.


Subject(s)
Education, Pharmacy/methods , Education, Pharmacy/standards , Pediatrics/education , Pediatrics/standards , Schools, Pharmacy/standards , Curriculum/standards , Faculty/standards , Humans , Intersectoral Collaboration , Pharmaceutical Services/standards , Pharmacy/methods , Pharmacy/standards , Students, Pharmacy
2.
J Pediatr Pharmacol Ther ; 24(4): 270-275, 2019.
Article in English | MEDLINE | ID: mdl-31337989

ABSTRACT

Technology and education are merging in today's society. Students in primary and secondary education recognize technology incorporated into teaching as a standard practice, not a unique experience. Curriculum standards in professional health sciences education have changed to promote the increased use of technology, with the purpose of enhancing student skills and engagement. The classroom and experiential settings offer opportunities for technology to be incorporated in a variety of ways. Technology can be useful for the teacher and student; however, challenges do exist. This paper highlights the benefits and challenges of incorporating technology into the settings of classroom and experiential teaching. Specifically, the purpose and use of technology, equipment, accessibility, time, and costs are discussed and example software programs are described.

3.
Pharmacotherapy ; 37(7): 824-839, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28543191

ABSTRACT

Pregnant women with opioid use disorder can be treated with methadone, buprenorphine, or naltrexone to reduce opioid use and improve retention to treatment. In this review, we compare the pregnancy outcomes of methadone, buprenorphine, and naltrexone in clinical trials and discuss the potential behavioral and developmental effects of these agents seen in offspring in animal studies. Important clinical considerations in the management of opioid use disorder in pregnant women and their infants are also discussed. Outside of pregnancy, buprenorphine is used in combination with naloxone to reduce opioid abuse and diversion. During pregnancy, however, the use of buprenorphine as a single agent is preferred to prevent prenatal naloxone exposure. Both methadone and buprenorphine are widely used to treat opioid use disorder; however, compared with methadone, buprenorphine is associated with shorter treatment duration, less medication needed to treat neonatal abstinence syndrome (NAS) symptoms, and shorter hospitalizations for neonates. Despite being the standard of care, medication-assisted treatment with methadone or buprenorphine is still underused, making it apparent that more options are necessary. Naltrexone is not a first-line treatment primarily because both detoxification and an opioid-free period are required. More research is needed to determine naltrexone safety and benefits in pregnant women. Animal studies suggest that changes in pain sensitivity, developmental processes, and behavioral responses may occur in children born to mothers receiving methadone, buprenorphine, or naltrexone and is an area that warrants future studies.


Subject(s)
Buprenorphine/therapeutic use , Methadone/therapeutic use , Naltrexone/therapeutic use , Opiate Substitution Treatment/methods , Opioid-Related Disorders/drug therapy , Pregnancy Complications/drug therapy , Analgesics, Opioid/adverse effects , Analgesics, Opioid/therapeutic use , Animals , Female , Humans , Infant, Newborn , Neonatal Abstinence Syndrome/diagnosis , Neonatal Abstinence Syndrome/drug therapy , Opioid-Related Disorders/diagnosis , Pregnancy , Pregnancy Complications/diagnosis , Treatment Outcome
4.
J Asthma ; 43(4): 311-7, 2006 May.
Article in English | MEDLINE | ID: mdl-16809246

ABSTRACT

OBJECTIVE: To evaluate knowledge and attitudinal outcomes of an educational asthma program for third-grade children with and without asthma. METHODOLOGY: "The Lion Who Couldn't Roar" was presented to third-grade classes in three Chicago area Counties. Participant asthma knowledge and attitudes were assessed via a print-based pretest-posttest design. Teacher satisfaction was also assessed. Data were analyzed using Rasch analysis before paired t tests were performed. RESULTS: Pre- and post-assessments were completed by 943 participants. A statistically significant increase in mean logit scores was identified on both knowledge and attitude evaluations (p < 0.001, p < 0.001). CONCLUSIONS: The results provide evidence of program impact.


Subject(s)
Asthma/therapy , Awareness , Patient Education as Topic/organization & administration , School Health Services/organization & administration , Asthma/diagnosis , Child , Female , Health Education/organization & administration , Health Knowledge, Attitudes, Practice , Humans , Male , Probability , Program Evaluation , Sampling Studies , Students
SELECTION OF CITATIONS
SEARCH DETAIL
...